Skip to content
Menu

Neumora Therapeutics, Inc. NMRA

Full chart Compare
Set alert

Price alert · NMRA

All alert types
0.33 USD -0.01 (-3.78%)

Regular-session close

0.32 -0.01 -4.16%

After hours · Nov 20, 7:02 PM ET

0.3011 Day range 0.3599
0.3339 52-week range 3.59
YTD
-81.35%
1 year
-85.85%

NMRA free cash flow history

Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.

Not available USD

FY 2025 · Period ended

Coverage: incomplete. Values in USD; not inflation adjusted.

Capital expenditure is reported net of asset sales as an inflow for some periods; free cash flow is not shown for them.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.

Missing observations.

Scroll the table to see all values →

Free cash flow · annual · USD
Fiscal periodPeriod endFree cash flowYoY changeYoY %
FY 20252025-12-31Not availableNot availableNot available
FY 20242024-12-31-182,936,000-19,541,000Not meaningful
FY 20232023-12-31-163,395,000-47,988,000Not meaningful
FY 20222022-12-31-115,407,000-39,170,000Not meaningful
FY 20212021-12-31-76,237,000Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-11-19T07:00:40.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.